Papers
Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies
BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7343.939 (Published 20 April 2002) Cite this as: BMJ 2002;324:939
Related articles
- This Week In The BMJ Published: 20 April 2002; BMJ 324 doi:10.1136/bmj.324.7343.0
- Correction Published: 08 June 2002; BMJ 324 doi:10.1136/bmj.324.7350.1357
See more
- Pulse oximetry may underestimate hypoxaemia in black patients, study findsBMJ December 21, 2020, 371 m4926; DOI: https://doi.org/10.1136/bmj.m4926
- Partha Kar: Our approach to tackling obesity needs rethinkingBMJ August 06, 2020, 370 m3034; DOI: https://doi.org/10.1136/bmj.m3034
- National registry will record patient outcomes from devices implanted during vascular surgeryBMJ July 24, 2020, 370 m2981; DOI: https://doi.org/10.1136/bmj.m2981
- Covid-19: Data show 5000 fewer hospital admissions for acute coronary syndrome during pandemicBMJ July 15, 2020, 370 m2852; DOI: https://doi.org/10.1136/bmj.m2852
- Covid-19: Pandemic is having “severe” impact on non-communicable disease care, WHO survey findsBMJ June 03, 2020, 369 m2210; DOI: https://doi.org/10.1136/bmj.m2210
Cited by...
- Patients With Diabetes Without Significant Angiographic Coronary Artery Disease Have the Same Risk of Myocardial Infarction as Patients Without Diabetes in a Real-World Population Receiving Appropriate Prophylactic Treatment
- Noninvasive Cardiovascular Risk Assessment of the Asymptomatic Diabetic Patient: The Imaging Council of the American College of Cardiology
- LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes
- The statin diabetes conundrum: short-term gain, long-term risk or inconvenient truth?
- Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3)
- Is Diabetes Mellitus a Heart Disease Equivalent in Women?: Results From an International Study of Postmenopausal Women in the Raloxifene Use for the Heart (RUTH) Trial
- Inclusion of Stroke in Cardiovascular Risk Prediction Instruments: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
- Long-Term Cardiovascular Risk in Type 2 Diabetic Compared With Nondiabetic First Acute Myocardial Infarction Patients: A population-based cohort study in southern Europe
- Unresolved Issues in the Management of Hypertension
- Should All Diabetic Patients Be Treated With a Statin?
- Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease
- Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People
- Role of statins for the primary prevention of cardiovascular disease in patients with type 2 diabetes mellitus
- Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association
- Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA study
- Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A scientific statement from the American Heart Association and the American Diabetes Association
- Statins for primary prevention in type 2 diabetes
- Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN)
- Diabetes and Coronary Risk Equivalency: What does it mean?
- Type 2 Diabetes as a "Coronary Heart Disease Equivalent": An 18-year prospective population-based study in Finnish subjects
- 2nd International Symposium on Triglycerides and HDL: Metabolic syndrome
- Should Diabetes Be Considered a Coronary Heart Disease Risk Equivalent?: Results from 25 years of follow-up in the Renfrew and Paisley Survey
- Increased Cardiovascular Morbidity and Mortality in Type 2 Diabetes Is Associated With the Glutathione S Transferase Theta-Null Genotype: A Go-DARTS Study
- The Gender-Specific Impact of Diabetes and Myocardial Infarction at Baseline and During Follow-Up on Mortality From All Causes and Coronary Heart Disease
- Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease
- Interplay of diabetes and coronary heart disease on cardiovascular mortality
- Cardiovascular Risk in Type 2 Diabetes Is Associated With Variation at the PPARG Locus: A Go-DARTS Study
- Cardiovascular Events in Diabetic and Nondiabetic Adults With or Without History of Myocardial Infarction
- Prognostic Value of Epicardial Coronary Artery Constriction to the Cold Pressor Test in Type 2 Diabetic Patients With Angiographically Normal Coronary Arteries and No Other Major Coronary Risk Factors
- Is Diabetes Mellitus a Cardiovascular Disease Risk Equivalent for Fatal Stroke in Women?: Data From the Women's Pooling Project
- Prediction of Coronary Heart Disease in Middle-Aged Adults With Diabetes
- Cardiovascular risk scores and prescribing in diabetes
- Impact of Incident Diabetes and Incident Nonfatal Cardiovascular Disease on 18-Year Mortality: The Multiple Risk Factor Intervention Trial experience
- Diabetics at Less Risk for Death from CAD than Patients with Prior MI